8 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
with epidemic risk ... patients are still at risk ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile Infection ... immunocompromised, IBD) • ↑Risk ... Lowest Risk: Tetracyclines ... Tx Management (IDSA ... #gastroenterology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... (Diffuse Pulmonary ... Coccidiodomycosis #IDSA ... Treatment #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Histoplasma Capsulatum Infections ... mm3 and at high risk ... Treatment #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... issue and the risk ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... viremia are strong risk ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Fluid Responsiveness and Fluid Tolerance Testing - OnePager Summary
Fluid resuscitation can be beneficial when required or
vasopressors and lower risk ... Pulmonary Artery ... via cold saline injection ... • PULMONARY A ... testing #diagnosis #criticalcare
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
400 mg PO qd) Risk ... PO qd) Severe infection ... Antimicrobial #empiric #idsa ... Adults #management #pharmacology